[ad_1]
Although the Food and Drug Authority has launched its surveillance program, which is concerned about the availability of drugs in the Kingdom, and officially launched the program after part of its budget was allocated for the launch of this program and the announcement of its launch, health service providers, pharmaceutical agents and suppliers were puzzled after asking "FDA" in his speech via his official account to provide data on the availability of drugs via Wake up!
According to the official website of the Authority, the program "Vigilance", launched for many years, aims to report side effects of drugs, medication errors and imbalances in the quality of preparations. Health care providers expressed surprise at what they described as confusion, in which the TRA had asked them to use an "awakening" program that did not concern the availability of drugs or supply chains. From a critical organ that affects the health of the community.
Meanwhile, Food and Drug Authority sources told "Okaz" that there is a difference between the "monitoring" and "awake" systems, launched last year.
The source said that the Drug Tracking System (Rasd) had established the Authority as part of its contribution plan to the 2020 National Transformation Program, which aimed to achieve the "Vision 2030 for Saudi Arabia". Arabia "by adopting the latest technical means to track and monitor all registered human medicines manufactured in the Kingdom or imported from abroad, This is due to the following objectives: Monitor the entire supply chain and stop the circulation of withdrawn medicines, warn them and make sure they are not.
The "Wake Up" system was created to allow the Authority's partners, all individuals, institutions and health institutions, to report on the availability of drugs, the shortage of stock, the lack commitment of agents to provide timely, or apologetic agents for the supply of registered drugs. Work to provide drugs by ordering new quantities prior to stock depletion from health authorities and health care service providers and pharmacies, in order to link the processes of manufacturing and shipping drugs and processing a number of administrative and laboratory procedures that may extend the supply period.
The Minister of Health, Dr. Tawfiq Al-Rabiah, inaugurated the electronic drug tracking system (Rasd) and confirmed that the goal of the program is to track pharmaceuticals electronically at all stages , from production to consumption, in order to guarantee the availability of medicines and guarantee their safety, in cooperation with public and private hospitals. , Dispensaries, health centers, government and commercial warehouses for importing and storing medicines, pharmaceutical factories, pharmacies and the final consumer of the drug.
Rasdad helps reduce the circulation of counterfeit products, provide medicines and find out where they are.
He explained that the system would contribute to the fight against fraud by controlling the functioning of the entire pharmaceutical supply chain and by providing reliable data on targeted drugs in fraud and sources of drugs counterfeited. He pointed out that the system also makes it possible to check the availability of drugs by obtaining information on the availability and location of the drug, to allow the consumer to know his data. It also strives to ensure the safety of medicines and to support the optimal use of the drug by directly stopping the circulation of drugs withdrawn with warning and guaranteeing In the absence of circulation, reduce the waste of drugs. drugs and know the actual consumption, and take advantage of drug use indicators to develop proactive plans.
He pointed out that the "surveillance" system would allow the Kingdom's health system to earn about 3 billion riyals a year.
[ad_2]
Source link
